In the United States, Group B Streptococcus (GBS) bacteria are a leading cause of meningitis and sepsis in a newborn’s first three months of life. The bacteria may be passed from pregnant women to their babies during delivery, because about one in every four pregnant women carry GBS bacteria in their body.
Companies and organizations that provide diagnostics serve an important role and must overcome many challenges inherent to developing diagnostic solutions. These areas include research and development, the regulatory environment, production and manufacturing, commercialization, and insurance and reimbursement.
In the past, the development of antimicrobial stewardship efforts mainly focused on prescribers and pharmacists. Today, as the threat of AMR increases, there is growing recognition of the need for efforts to also focus on other stakeholders in antibiotic use—particularly nurses